Remdesivir Appears Effective in COVID Outpatients, Too
Remdesivir (Veklury) reduced risk of hospitalizations by 87% compared with placebo in outpatients at high risk of progression to severe COVID-19, a researcher said. While the raw numbers were small — two in the remdesivir arm versus 15 in the placebo arm — the remdesivir arm had a significantly lower risk of hospitalization (0.7% vs […]